Viewing Study NCT03401320


Ignite Creation Date: 2025-12-25 @ 4:28 AM
Ignite Modification Date: 2026-01-16 @ 9:52 PM
Study NCT ID: NCT03401320
Status: COMPLETED
Last Update Posted: 2024-12-04
First Post: 2018-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of IM Letrozole ISMĀ® Pharmacokinetics, Safety, and Tolerability in Healthy Post-menopausal Women (LISA-1)
Sponsor: Rovi Pharmaceuticals Laboratories
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None pharmacokinetics View
None letrozole View